Current Edition


OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) (“OncBioMune” or the “Company”), a clinical-stage biopharmaceutical company …

Continue Reading →

Trump signs Right to Try Act for terminally ill patients

President Donald Trump has signed a bill giving terminally ill patients the right to try experimental treatments not approved by the government. Patients were able …

Continue Reading →